Venture Management

Immuto Scientific is a biotechnology services company that provides analytical insights to pharmaceutical companies for drug discovery.

AIQ Solutions, Inc. designs and develops medical devices and software solutions for quantitative assessment of individual lesions associated with complex diseases. The company develops a clinical decision support (CDS) platform that analyzes medical imaging data to identify all of a cancer patient’s lesions and quantify how they have changed after treatment. It provides quantitative total bone imaging (QTBI), a device that provides insights into metastatic bone disease from prostate or breast cancer. In addition, it offers quantitative total marrow imaging (QTMI), a device that measure heterogeneity and treatment response of disease in marrow. The company caters to oncologists, radiologists, nuclear med physicians, and pharmaceutical companies. AIQ Solutions, Inc. was founded in 2015 and is based in Madison, Wisconsin.

HealthMyne, Inc. is a healthcare informatics company based in Madison, Wisconsin, established in 2013. It specializes in providing innovative search, analytics, and imaging solutions primarily for cancer care providers. The company's smart imaging technology supports clinical decision-making by offering real-time, evidence-based insights that enhance diagnostic accuracy and foster collaboration among healthcare professionals. HealthMyne's platform includes features such as automatic tumor staging, dose overlays, specialized reporting, and management of incidental findings, all aimed at improving patient care and optimizing the efficiency of clinical workflows. By integrating electronic health record capabilities with advanced imaging solutions, HealthMyne seeks to reduce care delivery costs while ensuring that clinicians have access to relevant patient information for informed treatment decisions.

Swallow Solutions is dedicated to individuals suffering from swallowing disorders, generally known as dysphagia. It focus on two areas related to dysphagia – therapeutic devices for diagnosing and treating swallowing disorders and nutritional food products tailored to the patient’s diagnosed level of swallowing difficulty.

FluGen, Inc. is a biopharmaceutical company focused on developing vaccines to prevent diseases caused by influenza viruses. Founded in 2007 and based in Madison, Wisconsin, FluGen offers RedeeFlu, a nasal spray vaccine designed to protect against influenza, along with a vaccine-loaded intradermal microneedle delivery device. The company aims to address both seasonal and pandemic influenza on a global scale.

Invenra Inc. is a biopharmaceutical company specializing in the discovery of biologics, particularly antibodies and their derivatives. Founded in 2011 and located in Madison, Wisconsin, Invenra utilizes a proprietary technology that integrates cell-free expression of full-length antibodies with extreme miniaturization. This innovative approach allows for the screening of a vast number of full-length antibodies in phenotypic assays, facilitating the identification of next-generation biologics. The company boasts a strong scientific foundation and a team of experts with extensive knowledge in genomics, biochemistry, and bioengineering, blending advanced basic research with practical commercial applications.

NeuWave Medical develops tools that deliver energy to the human body to treat a variety of serious medical conditions. Their company founders are both engineers and physician-scientists which allows determining a clinical need and design solutions that are clinically relevant, effective, and minimally invasive. They strive to make the highest quality devices that are the products of choice for leading physicians and medical centers around the world. The company was founded in 2004 and is headquartered in Madison, Wisconsin.

Swallow Solutions is dedicated to individuals suffering from swallowing disorders, generally known as dysphagia. It focus on two areas related to dysphagia – therapeutic devices for diagnosing and treating swallowing disorders and nutritional food products tailored to the patient’s diagnosed level of swallowing difficulty.

Madison Vaccines, Inc. is a biopharmaceutical company based in Madison, Wisconsin, focused on developing therapeutic plasmid DNA vaccines for prostate cancer and its associated bone metastases. Founded by Douglas McNeel, M.D., Ph.D., and Richard Lesniewski, Ph.D., the company is working on two primary vaccines: pTVG-HP and pTVG-AR. The lead vaccine, pTVG-HP, is administered via intradermal injection and targets prostatic acid phosphatase (PAP), with ongoing Phase 2 clinical trials for men at high risk of developing bone metastases following prostate cancer treatment. Initial trials have shown promising biological and biochemical activity. The second vaccine, pTVG-AR, aims to target the androgen receptor, a key driver of prostate cancer growth, and is expected to enter clinical trials soon. Additionally, Madison Vaccines is developing a companion diagnostic test based on a novel blood signature identified by the McNeel lab, which could help predict patient responses to these vaccines.

Phoenix, LLC specializes in designing and manufacturing advanced nuclear and particle accelerator technologies, with a focus on high-yield neutron generators. These generators serve diverse applications, including neutron radiography, cargo screening, explosives detection, special nuclear material detection, and medical isotope production. The company also produces compact neutron generators used for nuclear fuel scanning and fast neutron radiography. Founded in 2005 and located in Madison, Wisconsin, Phoenix aims to commercialize nuclear technologies for practical uses across various sectors, including aerospace, defense, medical, and semiconductor industries. Additionally, the company is committed to its long-term vision of developing clean fusion energy solutions.

Silatronix, Inc. is a company based in Madison, Wisconsin, specializing in the development of organosilicon (OS) compounds and formulations for energy storage applications. Founded in 2007, the company focuses on creating organosilicon electrolytes used in both rechargeable and non-rechargeable lithium-ion batteries, as well as in ultracapacitors. Silatronix combines expert knowledge in organosilicon chemistry with advancements in nanostructured electrodes and the electronic properties of materials, aimed at enhancing the performance and efficiency of energy storage devices. Its innovative products are integral to the evolving landscape of energy storage technology.

Phoenix, LLC specializes in designing and manufacturing advanced nuclear and particle accelerator technologies, with a focus on high-yield neutron generators. These generators serve diverse applications, including neutron radiography, cargo screening, explosives detection, special nuclear material detection, and medical isotope production. The company also produces compact neutron generators used for nuclear fuel scanning and fast neutron radiography. Founded in 2005 and located in Madison, Wisconsin, Phoenix aims to commercialize nuclear technologies for practical uses across various sectors, including aerospace, defense, medical, and semiconductor industries. Additionally, the company is committed to its long-term vision of developing clean fusion energy solutions.

FluGen, Inc. is a biopharmaceutical company focused on developing vaccines to prevent diseases caused by influenza viruses. Founded in 2007 and based in Madison, Wisconsin, FluGen offers RedeeFlu, a nasal spray vaccine designed to protect against influenza, along with a vaccine-loaded intradermal microneedle delivery device. The company aims to address both seasonal and pandemic influenza on a global scale.

Madison Vaccines, Inc. is a biopharmaceutical company based in Madison, Wisconsin, focused on developing therapeutic plasmid DNA vaccines for prostate cancer and its associated bone metastases. Founded by Douglas McNeel, M.D., Ph.D., and Richard Lesniewski, Ph.D., the company is working on two primary vaccines: pTVG-HP and pTVG-AR. The lead vaccine, pTVG-HP, is administered via intradermal injection and targets prostatic acid phosphatase (PAP), with ongoing Phase 2 clinical trials for men at high risk of developing bone metastases following prostate cancer treatment. Initial trials have shown promising biological and biochemical activity. The second vaccine, pTVG-AR, aims to target the androgen receptor, a key driver of prostate cancer growth, and is expected to enter clinical trials soon. Additionally, Madison Vaccines is developing a companion diagnostic test based on a novel blood signature identified by the McNeel lab, which could help predict patient responses to these vaccines.

Swallow Solutions is dedicated to individuals suffering from swallowing disorders, generally known as dysphagia. It focus on two areas related to dysphagia – therapeutic devices for diagnosing and treating swallowing disorders and nutritional food products tailored to the patient’s diagnosed level of swallowing difficulty.

Silatronix, Inc. is a company based in Madison, Wisconsin, specializing in the development of organosilicon (OS) compounds and formulations for energy storage applications. Founded in 2007, the company focuses on creating organosilicon electrolytes used in both rechargeable and non-rechargeable lithium-ion batteries, as well as in ultracapacitors. Silatronix combines expert knowledge in organosilicon chemistry with advancements in nanostructured electrodes and the electronic properties of materials, aimed at enhancing the performance and efficiency of energy storage devices. Its innovative products are integral to the evolving landscape of energy storage technology.

SOLOMO Technology Inc. specializes in indoor location intelligence and personalized marketing solutions for retailers. The company offers the SOLOMO Exchange, a web-services platform that integrates with retailers' mobile applications to collect customer identity and location data, facilitating personalized offers while prioritizing customer control over their information. Its suite of tools includes SOLOMO Geo, which provides location-based notifications and usage reports, and SOLOMO Identity, enabling customers to manage their data. Additionally, SOLOMO offers Single Sign On for secure authentication and SOLOMO Intent for users to communicate their intentions to trusted organizations. The company also develops branded in-store mobile applications that enhance customer engagement and assist sales associates in providing better service. Founded in 2010 and based in Madison, Wisconsin, SOLOMO Technology focuses on delivering effective mobile solutions that enhance the retail experience while fostering customer trust.

Swallow Solutions is dedicated to individuals suffering from swallowing disorders, generally known as dysphagia. It focus on two areas related to dysphagia – therapeutic devices for diagnosing and treating swallowing disorders and nutritional food products tailored to the patient’s diagnosed level of swallowing difficulty.